These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2453008

  • 1. Intrapleural natural beta interferon in the treatment of malignant pleural effusions.
    Rosso R, Rimoldi R, Salvati F, De Palma M, Cinquegrana A, Nicolò G, Ardizzoni A, Fusco U, Capaccio A, Centofanti R.
    Oncology; 1988; 45(3):253-6. PubMed ID: 2453008
    [Abstract] [Full Text] [Related]

  • 2. Malignant pleural effusions.
    Sahn SA.
    Clin Chest Med; 1985 Mar; 6(1):113-25. PubMed ID: 2988851
    [Abstract] [Full Text] [Related]

  • 3. [Natural beta-interferon for local use in the treatment of metastatic pleural effusion caused by neoplasm of the breast].
    Terzoli E, Izzo F, Lucatelli S, Ranuzzi M.
    G Ital Oncol; 1989 Mar; 9(2-3):53-7. PubMed ID: 2767729
    [Abstract] [Full Text] [Related]

  • 4. Treatment of malignant pleural effusions with intracavitary Corynebacterium parvum.
    Casali A, Gionfra T, Rinaldi M, Tonachella R, Tropea F, Venturo I, De Martino C, Curcio CG.
    Cancer; 1988 Aug 15; 62(4):806-11. PubMed ID: 3293763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.
    Uchida A, Micksche M.
    Int J Cancer; 1983 Jan 15; 31(1):1-5. PubMed ID: 6219961
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drainage of recurrent pleural effusion via an implanted port and intrapleural catheter.
    Leff RS, Eisenberg B, Baisden CE, Mosley KR, Messerschmidt GL.
    Ann Intern Med; 1986 Feb 15; 104(2):208-9. PubMed ID: 3946948
    [No Abstract] [Full Text] [Related]

  • 9. The treatment of malignant pleural effusions.
    Anderson CB, Philpott GW, Ferguson TB.
    Cancer; 1974 Apr 15; 33(4):916-22. PubMed ID: 4362107
    [No Abstract] [Full Text] [Related]

  • 10. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
    Kaneto E, Sasaki H, Tamura I, Kurimura O, Kurimura T.
    Biken J; 1983 Jun 15; 26(2):99-102. PubMed ID: 6318725
    [Abstract] [Full Text] [Related]

  • 11. [Intrapleural bleomycin for management of malignant pleural effusions].
    Sugita T, Matsunaga K, Kobayashi H, Horikawa S, Suzuki Y, Nishiyama H, Maekawa N, Furuta H, Inui H, Fujimoto H.
    Gan To Kagaku Ryoho; 1995 Aug 15; 22(9):1203-7. PubMed ID: 7544964
    [Abstract] [Full Text] [Related]

  • 12. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.
    Rossi GA, Felletti R, Balbi B, Sacco O, Cosulich E, Risso A, Melioli G, Ravazzoni C.
    Am Rev Respir Dis; 1987 Apr 15; 135(4):885-90. PubMed ID: 2436513
    [Abstract] [Full Text] [Related]

  • 13. [Fibrin glue and tetracycline pleurodesis in recurrent malignant pleural effusions. A randomized comparative study].
    Gust R, Kleine P, Fabel H.
    Med Klin (Munich); 1990 Jan 15; 85(1):18-23. PubMed ID: 1690342
    [Abstract] [Full Text] [Related]

  • 14. [Management of malignant pleural effusion by tetracycline pleurodesis].
    Horváth T, Orosz E, Czenkár B.
    Orv Hetil; 1989 May 14; 130(20):1051-2. PubMed ID: 2471952
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Local administration of recombinant interferon-beta to patients with cancer-associated body cavity fluids].
    Tanaka N, Terasawa A, Matsui T, Yamada J, Hizuta A, Ichikawa J, Nakayama F, Matsuda T, Orita K.
    Gan To Kagaku Ryoho; 1988 Feb 14; 15(2):237-41. PubMed ID: 3341785
    [Abstract] [Full Text] [Related]

  • 17. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S, Terman DS, Bohach G, Silvers A, Hansen C, Colt H, Sahn SA.
    Chest; 2004 Nov 14; 126(5):1529-39. PubMed ID: 15539723
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar 14; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.